EMA — authorised 13 February 2020
- Marketing authorisation holder: Merck Sharp & Dohme B.V.
- Status: approved
🇪🇺 Primaxin in European Union
EMA authorised Primaxin on 13 February 2020
Marketing authorisation
Primaxin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in European Union
Frequently asked questions
Is Primaxin approved in European Union?
Yes. EMA authorised it on 13 February 2020.
Who is the marketing authorisation holder for Primaxin in European Union?
Merck Sharp & Dohme B.V. holds the EU marketing authorisation.